The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(2-chloro-7-((4-methylpiperazin-1-yl)methyl)naphthalen-1-yl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione ID: ALA4068028
PubChem CID: 11547825
Max Phase: Preclinical
Molecular Formula: C29H27ClN4O2
Molecular Weight: 499.01
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(Cc2ccc3ccc(Cl)c(C4=C(c5cn(C)c6ccccc56)C(=O)NC4=O)c3c2)CC1
Standard InChI: InChI=1S/C29H27ClN4O2/c1-32-11-13-34(14-12-32)16-18-7-8-19-9-10-23(30)25(21(19)15-18)27-26(28(35)31-29(27)36)22-17-33(2)24-6-4-3-5-20(22)24/h3-10,15,17H,11-14,16H2,1-2H3,(H,31,35,36)
Standard InChI Key: BNAXHIOTDMDOLF-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 41 0 0 0 0 0 0 0 0999 V2000
14.0325 -2.1957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8497 -2.1957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1041 -1.4190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4411 -0.9369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7824 -1.4190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3266 -2.8556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0732 -3.6325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7338 -4.1136 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1438 -2.8566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3938 -3.6305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1874 -3.7997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7319 -3.1958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4772 -2.4201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6842 -2.2546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3855 -2.8429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6114 -2.5674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9887 -3.1006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1393 -3.9081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5376 -3.6446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9190 -4.1771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0715 -4.9770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8420 -5.2456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4603 -4.7081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3047 -3.9101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8817 -1.1676 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0051 -1.1668 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4626 -1.7639 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.7348 -4.9308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2331 -4.9739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3893 -5.7760 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7702 -6.3076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9238 -7.1066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6955 -7.3765 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3141 -6.8410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1610 -6.0356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8487 -8.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 10 1 0
9 6 1 0
2 6 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
1 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 20 1 0
19 15 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 19 2 0
3 25 2 0
5 26 2 0
16 27 1 0
8 28 1 0
23 29 1 0
29 30 1 0
30 31 1 0
30 35 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
33 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 499.01Molecular Weight (Monoisotopic): 498.1823AlogP: 4.30#Rotatable Bonds: 4Polar Surface Area: 57.58Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.87CX Basic pKa: 7.95CX LogP: 4.40CX LogD: 3.74Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.43Np Likeness Score: -0.75
References 1. van Eis MJ, Evenou J, Schuler W, Zenke G, Vangrevelinghe E, Wagner J, von Matt P.. (2017) Indolyl-naphthyl-maleimides as potent and selective inhibitors of protein kinase C-α/β., 27 (4): [PMID:28131714 ] [10.1016/j.bmcl.2017.01.038 ]